Medscape Medical NewsAll articles

WRDensity by Whiterabbit.ai

Whiterabbit.ai Inc. • Radiology • 10/30/2020

510(k)IEC 62304 Class B
FDA Summary PDF

Device Purpose

WRDensity is a software application that employs a deep learning algorithm to automatically analyze digital mammography images, providing an ACR BI-RADS breast density category to aid physicians in assessing breast tissue composition. The system, which processes DICOM images and outputs results to PACS/RIS, demonstrated strong performance with a quadratically-weighted Cohen's kappa of 0.90 when compared to a consensus of five expert radiologists for the four-class density task.

Summary

WRDensity by Whiterabbit.ai is a standalone software application designed to assist interpreting physicians in the assessment of breast tissue composition. It utilizes a deep learning algorithm to automatically analyze 'for presentation' data from compatible full-field digital mammography (FFDM) and digital breast tomosynthesis (DBT) systems. The software processes DICOM images transferred from a facility’s mammography system, PACS, or DICOM router. Its primary output is the Breast Density Level (BDL), a categorical assessment according to the American College of Radiology (ACR) BI-RADS Atlas 5th Edition breast density categories (A through D). A secondary output, Breast Density Level Probabilities (BDLP), provides the probabilities for each of the four density categories, offering insight into the device's confidence. These outputs are then sent to PACS and Radiology Information Systems (RIS) for review by radiologists as DICOM Secondary Capture Images or Structured Reports. The performance of WRDensity was evaluated through software verification and validation, including comparison against a consensus of five expert radiologists on a test dataset of 871 unique patient exams representing all compatible modalities. For the four-class BI-RADS task, WRDensity achieved a quadratically-weighted Cohen’s kappa of 0.90 (95% CI [0.88, 0.92]), indicating high agreement with the radiologist consensus. For a binary task (dense vs. non-dense tissue), it achieved a Cohen’s kappa of 0.88 (95% CI [0.85, 0.91]). The software also underwent consistency assessment, evaluating agreement between MLO and CC views of the same breast, and reproducibility testing. WRDensity is intended to provide adjunctive information and is not a diagnostic aid.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

Breast DensityDeep LearningMammographyBI-RADSDICOMRadiological Image ProcessingSoftwareAdjunctive InformationCohen's KappaAutomated Assessment

Device Metadata

Submission Number
K202013
Company
Whiterabbit.ai Inc.
Panel
Radiology
Product Code
N/A
Data Type
Images
Clinical Function
Assessment
AI Function
Analysis
AI Subclass
quantification/feature localization

Relevant Clinical Questions

  • Q1. How does the performance of WRDensity vary across different mammography machine vendors and models not explicitly listed as compatible, and what is the process for validating new systems?; What specific deep learning architecture is employed by WRDensity, and what were the key considerations for its selection and training in assessing breast density?; Beyond Cohen's kappa, what are the specific false positive and false negative rates for each individual BI-RADS category (A, B, C, D), and how might these impact clinical workflow or patient management decisions?; How does the 'Breast Density Level Probabilities (BDLP)' output, particularly the device's confidence level, correlate with instances of discordance between WRDensity and radiologist consensus, and can this be used to flag challenging cases?; What was the variability in breast density assessment among the five expert radiologists in the consensus panel, and how does WRDensity's performance compare to individual radiologist performance within that panel?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score5/100
SBOM Evidence⚠ Not mentioned in summary
Cyber Risk Assessment⚠ Not mentioned in summary
Postmarket Plan⚠ Not mentioned in summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(deep learning, algorithm, dataset)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials
- Not detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, SaaSBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
WRDensity by Whiterabbit.ai - Whiterabbit.ai Inc. | ESL FDA AI Device Intelligence